Table 1.
Demographic and Clinical Information
| SZP Group (n = 48) | Control Group (n = 28) | |
|---|---|---|
|
| ||
| Sex (% male) | 83.3 | 92.8 |
|
| ||
| Race/ethnicity (% Caucasian) | 58.3 | 96.4 |
|
| ||
| Age (years) | 40.78 (11.76) | 43.62 (9.49) |
| Education (years) | 11.57 (1.76) | 16.07 (1.83) |
|
| ||
| Parental Education (years) | 12.51 (2.12) | 12.55 (2.18) |
|
| ||
| Mini-Mental State Examination (out of 30) | 26.21 (2.6) | 29.23 (.81) |
|
| ||
| Medication | ||
| Chlorpromazine equivalents | 335.36 (355.8) | |
| Range | 0 – 1906.82 | |
| % taking antipsychotics | 97.91 | |
| % taking mood stabilizers | 43.75 | |
| % taking antidepressants | 56.25 | |
| % taking anticholinergics | 18.75 | |
| % taking anxiolytics | 29.17 | |
|
| ||
| SAPS Global Ratings M (SD) | ||
|
| ||
| Hallucinations | 1.88 (1.89) | |
|
| ||
| Delusions | 2.87 (1.41) | |
|
| ||
| Positive Formal Thought Disorder | 1.72 (1.5) | |
|
| ||
| Physical Anhedonia Scale | 16.92 (7.71) | 11.5 (6.91) |
|
| ||
| Social Anhedonia Scale | 15.78 (6.73) | 10.36 (7.69) |
Note: SAPS - Scale for the Assessment of Positive Symptoms